Authors:
GUEDDARI N
BOBICHON H
DEPIERREUX C
LIAUTAUDROGER F
DURIEZ P
DUFER J
JARDILLIER JC
Citation: N. Gueddari et al., ENHANCEMENT OF ALL-TRANS-RETINOIC ACID EFFICIENCY IN GRANULOCYTIC DIFFERENTIATION OF HL-60 CELLS BY INCORPORATION INTO LOW-DENSITY-LIPOPROTEIN, International journal of oncology, 13(5), 1998, pp. 1069-1075
Citation: Jc. Fruchart et P. Duriez, HIGH-DENSITY-LIPOPROTEINS AND CORONARY HEART-DISEASE - FUTURE-PROSPECTS IN GENE-THERAPY, Biochimie, 80(2), 1998, pp. 167-172
Authors:
WALTERSLAPORTE E
FURMAN C
FOUQUET S
MARTINNIZARD F
LESTAVEL S
GOZZO A
LESIEUR D
FRUCHART JC
DURIEZ P
TEISSIER E
Citation: E. Walterslaporte et al., A HIGH-CONCENTRATION OF MELATONIN INHIBITS IN-VITRO LDL PEROXIDATION BUT NOT OXIDIZED LDL TOXICITY TOWARD CULTURED ENDOTHELIAL-CELLS, Journal of cardiovascular pharmacology, 32(4), 1998, pp. 582-592
Authors:
GUERCI B
MEYER L
BOULLIER A
DURIEZ P
FRUCHART JC
DROUIN P
Citation: B. Guerci et al., INTRAPERITONEAL INSULIN INFUSION DOES NOT INFLUENCE CHOLESTEROL EFFLUX IN WELL-CONTROLLED IDDM PATIENTS, Diabetes, 47, 1998, pp. 393-393
Authors:
DELERIVE P
MARTIN F
CHINETTI G
TROTTEIN F
FRUCHART JC
DURIEZ P
STAELS B
Citation: P. Delerive et al., PPAR ACTIVATORS INHIBIT THROMBIN-INDUCED ENDOTHELIN-1 PRODUCTION IN HUMAN VASCULAR ENDOTHELIAL-CELLS, Circulation, 98(17), 1998, pp. 2137-2137
Authors:
BERNARD F
REVEL F
MONSEGU J
DURIEZ P
LANGLADE S
OLLIVIER JP
Citation: F. Bernard et al., CORONARY VESSEL ECTASIA - CORONARY-ARTERY DISEASE WITH A HIGH THROMBOEMBOLIC RISK, Annales de cardiologie et d'angeiologie, 47(3), 1998, pp. 160-164
Citation: Jc. Fruchart et P. Duriez, REVERSE CHOLESTEROL TRANSPORT AND UTILIZA TION OF TRANSGENIC MICE ANDTRANSGENIC RABBITS TO EVIDENCE PROTECTIVE GENES AGAINST ATHEROSCLEROSIS DEVELOPMENT, Bulletin de l'Academie nationale de medecine, 182(2), 1998, pp. 233-249
Authors:
PERRY DK
SMYTH MJ
WANG HG
REED JC
DURIEZ P
POIRIER GG
OBEID LM
HANNUN YA
Citation: Dk. Perry et al., BCL-2 ACTS UPSTREAM OF THE PARP PROTEASE AND PREVENTS ITS ACTIVATION, Cell death and differentiation, 4(1), 1997, pp. 29-33
Authors:
PERRY DK
SMYTH MJ
WANG HG
REED JC
DURIEZ P
POIRIER GG
OBEID LM
HANNUN YA
Citation: Dk. Perry et al., BCL-2 ACTS UPSTREAM OF THE PARP PROTEASE AND PREVENTS ITS ACTIVATION, Cell death and differentiation, 4(1), 1997, pp. 29-33
Authors:
BARD JM
LUC G
JUDE B
BORDET JC
LACROIX B
BONTE JP
PARRA HJ
DURIEZ P
Citation: Jm. Bard et al., A THERAPEUTIC DOSAGE (3 G DAY) OF BORAGE OIL SUPPLEMENTATION HAS NO EFFECT ON PLATELET-AGGREGATION IN HEALTHY-VOLUNTEERS/, Fundamental and clinical pharmacology, 11(2), 1997, pp. 143-144
Authors:
PERRY DK
SMYTH MJ
STENNICKE HR
SALVESEN GS
DURIEZ P
POIRIER GG
HANNUN YA
Citation: Dk. Perry et al., ZINC IS A POTENT INHIBITOR OF THE APOPTOTIC PROTEASE, CASPASE-3 - A NOVEL TARGET FOR ZINC IN THE INHIBITION OF APOPTOSIS, The Journal of biological chemistry, 272(30), 1997, pp. 18530-18533
Authors:
BOULLIER A
HENNUYER N
DUVERGER N
EMMANUEL F
TAILLEUX A
FIEVET C
DENEFLE P
FRUCHART JC
CASTRO GR
DURIEZ P
Citation: A. Boullier et al., EVOLUTION OF IMMUNOLOGICAL MARKERS OF LDL OXIDATION IN CHOLESTEROL-FED HUMAN APOLIPOPROTEIN AI TRANSGENIC RABBITS, Atherosclerosis, 134(1-2), 1997, pp. 32-32
Citation: P. Duriez et al., EFFECT OF FISH-OIL (MAXEPA) ON ATHEROGENIC LIPOPROTEIN PARTICLES DEFINED BY APOLIPOPROTEIN COMPOSITION (LPE-B, LPC-III-B) IN PATIENTS WITH MIXED HYPERLIPIDEMIA, Atherosclerosis, 134(1-2), 1997, pp. 55-55
Authors:
DURIEZ P
LUC G
JUDE B
BORDET JC
LACROIX B
BONTE JP
PARRA HJ
BARD JM
Citation: P. Duriez et al., THERAPEUTIC DOSAGE (3 G DAY) OF BORAGE OIL SUPPLEMENTATION HAS NO EFFECT ON PLATELET-AGGREGATION IN HEALTHY-VOLUNTEERS/, Atherosclerosis, 134(1-2), 1997, pp. 189-189
Authors:
FURMAN C
MARTIN F
FRUCHART JC
DURIEZ P
TEISSIER E
Citation: C. Furman et al., DIFFERENTIAL-EFFECTS OF AIR (MO-LDL) OR COPPER OXIDIZED LDLS (CU-LDL)ON ENDOTHELIAL-CELL GSH CONTENT, Atherosclerosis, 134(1-2), 1997, pp. 222-222
Authors:
GUERCI B
MEYER L
BOULLIER A
DURIEZ P
FRUCHART JC
DROUIN P
Citation: B. Guerci et al., INTRAPERITONEAL INSULIN INFUSION DOES NOT INFLUENCE LDL SUSCEPTIBILITY TO OXIDATION IN WELL-CONTROLLED IDDM PATIENTS, Diabetes, 46, 1997, pp. 624-624
Authors:
LEBUFFE G
BOULLIER A
TAILLEUX A
DELFLY B
DUPUIS B
FRUCHART JC
DUVERGER N
EMMANUEL F
DENEFLE P
VALLET B
DURIEZ P
Citation: G. Lebuffe et al., ENDOTHELIAL-DERIVED VASORELAXATION IS IMPAIRED IN HUMAN APO A-I TRANSGENIC RABBITS, Biochemical and biophysical research communications, 241(1), 1997, pp. 205-211
Citation: P. Duriez, CONTRIBUTION OF GENETICALLY-MODIFIED ANIM ALS TO STUDY OF LIPOPROTEINMETABOLISM, Archives of physiology and biochemistry, 104(4), 1996, pp. 4-8
Authors:
IGAU B
LESTAVEL S
CLAVEY V
SLOMIANNY C
DROUIN P
BRESSON R
FRUCHART JC
DURIEZ P
FIEVET C
Citation: B. Igau et al., APO B-CONTAINING LIPOPROTEIN PARTICLES IN POORLY CONTROLLED INSULIN-DEPENDENT DIABETES, Atherosclerosis, 120(1-2), 1996, pp. 209-219
Citation: Jc. Fruchart et al., APOLIPOPROTEIN-AI-CONTAINING PARTICLES AND ATHEROSCLEROSIS, Israel journal of medical sciences, 32(6), 1996, pp. 498-502